Universal Sample Bank

USB blood sampleThe Association for Diagnostics & Laboratory Medicine’s (ADLM) Universal Sample Bank provides well-characterized blood samples, including plasma and serum, that can be used in a variety of clinical studies, including clinical assay development, standardization, and reference range studies. Full sets, individual samples, and custom orders can be arranged.

Features of ADLM’s Universal Sample Bank Include

ADLM offers pre-screened and well-characterized sample sets from over 700 healthy individuals. The sample set can be used in a variety of clinical studies, including clinical assay development, standardization, and reference range studies. Features of ADLM’s Universal Sample Bank include:

  • Serum/ plasma samples available from 700+ healthy individuals
  • Ethnically and geographically diverse adult population (18+)
  • IRB-approved collection protocol
  • Comprehensive de-identified donor data with health screening information
  • Results of HbA1c, Creatinine, and NT-proBNP screens
  • Samples collected as part of the COVID Immunity Study
    • Biotin and hsCRP data
    • Comprehensive COVID-specific data

International shipping is available.

Complete the form below to let us know your needs or contact Caitlin Ondracek at condracek@myadlm.org for more information.

Special Offer

ADLM offers a discounted price for ADLM members who purchase the sample sets for academic research purposes.

We received over 800 samples from unique healthy donors. The data provided was very valuable for my research and helped us establish new reference intervals for emerging biomarkers of cardiac and kidney disease...

—Joe El-Khoury, PhD, DABCC, FADLM, Director, Clinical Chemistry Laboratory, Yale-New Haven Health

How it's contributing to research

  • The first paper from the ADLM COVID Immunity Study has been published in Frontiers in Public Health. This paper focused on the results of the general health and COVID-specific questionnaires and illustrates differences in side effects between Moderna, Pfizer, and Johnson & Johnson vaccines. Learn more.
  • New research from the ADLM COVID Immunity Study demonstrated that neutralizing antibody responses can serve as predictors of breakthrough infection and that T cell assays may aid in predicting breakthrough disease severity after SARS-CoV-2 vaccination.